Open Access · CC BY-NC-ND 4.0
WCN26-6423 Pemigatinib-Associated Calciphylaxis versus Calcinosis Cutis in Metastatic Cholangiocarcinoma
Kidney International Reports · 2026-04 · 11 (4) · 104166
DOI: 10.1016/j.ekir.2026.104166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International Reports, 2026-04. Verfasst von Archee Singh und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Singh, A., Hepburn, K., & Chau, K. (2026). WCN26-6423 Pemigatinib-Associated Calciphylaxis versus Calcinosis Cutis in Metastatic Cholangiocarcinoma. Kidney International Reports, 11(4), 104166. https://doi.org/10.1016/j.ekir.2026.104166
Vancouver
Singh A, Hepburn K, Chau K. WCN26-6423 Pemigatinib-Associated Calciphylaxis versus Calcinosis Cutis in Metastatic Cholangiocarcinoma. Kidney International Reports. 2026;11(4):104166. doi:10.1016/j.ekir.2026.104166
BibTeX
@article{Singh2026,
author = {Singh, Archee and Hepburn, Kirsten and Chau, Ken},
title = {WCN26-6423 Pemigatinib-Associated Calciphylaxis versus Calcinosis Cutis in Metastatic Cholangiocarcinoma},
journal = {Kidney International Reports},
year = {2026},
volume = {11},
number = {4},
pages = {104166},
doi = {10.1016/j.ekir.2026.104166}
}
EUVIMED